Bradley Moore, USCD
100 Friday Center Dr, Chapel Hill, NC
Titled "Personalized Medicine, the Cancer Genome Atlas and the Future of Cancer Care," this year's symposium will be held April 8-9, 2015 at the Friday Center in Chapel Hill, NC.
Alan Engelman, PhD, Professor of Medicine, Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard School of Medicine
Jeffrey N. Weiser, M.D., NYU, School of Medicine
Thomas C. Ricketts, III, PhD, MPH, Deputy Director for Policy Analysis, Cecil G. Sheps Center for Health Services Research, Professor, Health Policy & Management and Social Medicine, University of North Carolina at Chapel Hill
Vincent B. Young, MD, PhD, University of Michigan
Alba Guarné, PhD, Associate Professor of Biochemistry and Biomedical Sciences at McMaster University
Susan Golden, Ph.D., University of California, San Diego
The Science of Breast Cancer Disparities: A Symposium in Honor of the Carolina Breast Cancer Study and Robert Millikan
This special symposium will honor the scientific contributions of Dr. Robert Millikan to understanding the causes of breast cancer, especially among African-American women. The symposium will provide an overview of the Carolina Breast Cancer Study the landmark study that Dr. Millikan led as well as a current perspective on the epidemiology and biology of breast cancer. The role of science and breast cancer advocacy, an area of commitment to Dr. Millikan, will also be discussed. Presentations will be provided by Dr. Millikan’s UNC colleagues and other national leaders in breast cancer research.
Chromatin architecture, CTCF and V(D)J recombination: Managing long-distance relationships at the Tcra/Tcrd locus
Michael S. Krangel, PhD, Professor and Chair, Department of Immunology, Duke University Medical Center